0001203311-21-000053.txt : 20210813 0001203311-21-000053.hdr.sgml : 20210813 20210813213953 ACCESSION NUMBER: 0001203311-21-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210813 FILED AS OF DATE: 20210813 DATE AS OF CHANGE: 20210813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DANSEY ROGER D CENTRAL INDEX KEY: 0001741836 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 211174138 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-08-13 0 0001060736 Seagen Inc. SGEN 0001741836 DANSEY ROGER D 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Chief Medical Officer Common Stock 2021-08-13 4 S 0 9900 156.58 D 74535 D Common Stock 2021-08-13 4 S 0 100 157.25 D 74435 D Reflects sales of common stock executed in multiple transactions at prices ranging from $156.25 to $157.23 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. By: /s/ Elizabeth Bekiroglu For: Roger D Dansey 2021-08-13